J2503 HCPCS Level II code: Injection, pegaptanib sodium, 0.3 mg

CMS terminated J2503: its last date of service was Sep 30, 2025. It stays here for looking up older claims; newer services need a current code.

Official description

J2503

Injection, pegaptanib sodium, 0.3 mg

Short description: Pegaptanib sodium injection

HCPCS · United States

Notes for J2503

As CMS prints them, with any note J2503 takes from the headings above it.

Note

  • CMS processing note 0095: AS REQUIRED BY BBRA SECTION 201.

Medicare details

The indicators CMS publishes with J2503 in its October 2026 file. They describe Medicare’s handling, not another payer’s.

Medicare coverage
Carrier judgment
Medicare pricing
Drugs
Type of service
Medical care; Lump sum purchase of DME, prosthetics, orthotics
BETOS category
Other drugs
Added
Jan 1, 2006
Terminated after
Sep 30, 2025

Where J2503 sits

  1. 1J codesDrugs administered other than orally
  2. 2Terminated J2503Injection, pegaptanib sodium, 0.3 mg

Source and release

Data release
HCPCS Level II · October 2026
Effective date
Oct 1, 2026
Publisher
CMS

This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.

Frequently asked questions

Is HCPCS code J2503 still valid?

No. CMS terminated J2503; its last date of service was Sep 30, 2025. It is listed for looking up services from before then. Use a current code for newer services.

Does Medicare cover J2503?

CMS lists J2503’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.

Which HCPCS Level II release does this page use?

It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.